About: http://data.cimple.eu/news-article/8bf4460773a7b2de090b0c471f1a6329eeda4b029614dc53cb962bc7

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/8bf4460773a7b2de090b0c471f1a6329eeda4b029614dc53cb962bc7 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Remdesivir, a therapeutic to treat Covid-19, boosted third-quarter sales for pharmaceutical company Gilead Sciences by nearly $900 million, according to results released Wednesday by the drugmaker. The medication, sold under the brand name Veklury and originally developed to treat Ebola, has been shown to shorten the recovery time for patients hospitalized with the new coronavirus. Gilead reported a 17 percent jump in third-quarter revenues to $6.6 billion. The company reported a profit of $360 million, compared with a loss of $1.2 billion in the year-ago period. The US Food and Drug Administration last Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May. Remdesivir, which is administered by an injection, was one of the first drugs to show relative promise in treating the virus, although its efficacy in reducing its mortality rate is unproven. President Donald Trump, who tested positive for the coronavirus early in October, was treated with remdesivir -- among other drugs -- at a military hospital outside Washington. Shares of Gilead fell 1.4 percent to 57.90 in after-hours trading. jum-jmb/caw
schema:headline	Gilead Sciences reports almost $900 mn in Q3 remdesivir sales
schema:mentions	Case fatality rate Antiviral drug Remdesivir Medication University of Washington Ebola virus disease Severe acute respiratory syndrome coronavirus 2 President of the United States Donald Trump Coronavirus disease 2019 Extended-hours trading Gilead Sciences Canadian Auto Workers
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-10-28 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	75 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...romotesConspiracy	suppressed cures conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software